InjectCo review

What it is

InjectCo is a chain of medical aesthetic clinics founded in July 2021 by Kiara DeWitt, a registered nurse and nurse injector, with locations in Colleyville, Plano, Waxahachie, Argyle, The Woodlands, Fort Worth, Dallas, Austin and Cleburne. Most of its business is cosmetic: wrinkle relaxers, dermal fillers, lasers and body contouring, plus a training academy for injectors. Weight management is a separate line that includes compounded semaglutide injections, compounded tirzepatide injections, sublingual semaglutide drops and a structured program it calls BriteBody. Its online program page says it serves patients across the United States, while most of its weight-loss pages are written for Texas. Care is provided by registered nurses, nurse practitioners and physician assistants working under a supervising physician. Its terms are governed by Texas law, with disputes heard in Collin County. Spanish-speaking staff are available.

How it works

You start with a secure online health form covering your medical history, current medications, weight and goals. Next comes a virtual consultation, in which one of its nurse injectors or physician assistants reviews your information and answers questions. A licensed provider then decides whether treatment is appropriate and, if it is, writes a prescription that a pharmacy ships to your home in discreet packaging. From there, the program includes telehealth follow-ups, progress tracking, dose adjustments and nutrition and lifestyle guidance, and the site says follow-up appointments are free. Its online program page says candidates generally have a BMI over 30, or 27 or higher with a weight-related condition, and that the treatment isn't advised during pregnancy or breastfeeding. If you live in Texas, you can also visit one of its clinics, where nurses can teach you to inject. In October 2026, the "Start Online Evaluation" button on its weight-loss pages opened a form marked unavailable, so calling or texting the clinic line may be the quickest way in.

Pricing transparency

InjectCo's prices don't line up across its own pages. The compounded semaglutide page lists $249 a month. The online program page lists the semaglutide program and the tirzepatide program at $425 a month each, and the tirzepatide page also says $425 a month. The general pricing page shows the weight-loss program at $425 a month or $1,800 for a six-to-eight-month program. According to the tirzepatide page, the monthly fee covers medication, injection supplies, injection training, provider consultations, dose adjustments and monthly delivery, and the drops page says the price doesn't rise as your dose goes up. There's no membership fee on top. You can cancel by contacting the clinic before your next delivery, with no long-term contract. The fee is self-pay; HSA and FSA cards are accepted, and financing is available through CareCredit or Cherry Pay, with a 6% fee. The site's general terms say sales are final for completed services, and refunds for prepaid packages are at the company's discretion. A pop-up promises savings of up to $350 for qualifying patients through October 31, so ask how that changes the bill.

Branded vs compounded

InjectCo offers compounded semaglutide and compounded tirzepatide as weekly injections, and compounded semaglutide as daily drops under the tongue. Compounded medications are not FDA-approved, which its own pages state plainly. The weight-loss pages say medication comes from a licensed 503B pharmacy, while the drops page names Striker Pharmacy in Katy, Texas as its dispensing pharmacy, so ask which pharmacy will fill your order. Its claims that the drops work about as well as injections, with fewer side effects, come from the company rather than from trials of the drops themselves. The weight-loss figures on the tirzepatide page come from the SURMOUNT-1 trial of the brand-name drug, not from InjectCo's patients. Brand-name Wegovy, Ozempic, Zepbound and Mounjaro aren't offered. The site shows a LegitScript image linked to LegitScript's lookup page rather than a numbered seal. A search of the FDA warning-letter database under the company's name returned no letters.

Pros and watch-outs

The evidence behind what InjectCo prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How InjectCo compares

A few alternatives worth a look, depending on what you’re optimizing for.

• HUHumeCare+

  Tracking lean mass rather than scale weight, if you read the guarantee terms first

  See HumeCare+ →
• SkinnyRx

  Straightforward compounded GLP-1 access with cancel-anytime flexibility

  See SkinnyRx →
• Green Cap Health

  Texas residents who want a local practice, monthly billing and regular provider calls

  See Green Cap Health →

More GLP-1 telehealth reviews: Eden · WellMedRx · Sprout Health · Wellorithm · TrimRx · altRx